CClinicalTrials.gg
Status unknownNCT01327560Updated Apr 1, 2011

Sleep Quality and Related Factors in Hemodialysis Patients

An observational study in Haemodialysis-induced Symptom, sponsored by Taipei Medical University WanFang Hospital. Status unknown at 1 site in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2011-04-01.

Sponsored by Taipei Medical University WanFang Hospital · Observational

The sponsor has not verified this record recently (last verified Mar 2011), so the status shown — last known as Enrolling by invitation — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
200
Ages
20 Years and older
Sex
All
01

Study summary

Sleep quality is an important predictor of healthy status,quality of life and life span. Sleeping problems affect 50%\~80% in hemodialysis patients. Sleep quality and related factors research in hemodialysis patients has been discussed and studied globally. Previous studies show insomnia, excessive daytime sleepiness(EDS), sleep apnea syndrome(SAS), restless legs syndrome(RLS) are major causes of poor sleep quality . There is few data to show the influential factors related to sleep quality in Taiwanese hemodialysis patients.

Read the detailed description

This study will be a cross-sectional design with purposive sample from 2 different dialysis medical centers in Taipei. Two hundred hemodialysis patients meeting inclusion criteria will be recruited.

02

Conditions studied

  • Haemodialysis-induced Symptom

Keywords

  • hemodialysis patients
  • sleep quality
  • restless legs syndrome
  • excessive daytime sleepiness
  • sleep apnea syndrome
03

In context

Lead sponsor

Taipei Medical University WanFang Hospital is the lead sponsor of 196 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Hemodialysis Patients

Inclusion criteria

  • Hemodialysis patient whose age ≧ 20 years old and conscious clear.
  • ICD9:585.6
  • Every week receives two or three convention hemodialysis treatment above three months.
  • May communication with Mandarin or Taiwanese language.
  • Patient or caregiver is willing to participate study and sign the inform consent.

Exclusion criteria

Exclusion Criteria:

  • Hospitalized hemodialysis patient in recently one month.
  • Hemodialysis patient had conscious disturbance, blind or dementia.
  • Hemodialysis Patient refuse to interview or fill out questionnaires.
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
200 participants (estimated)
06

Study locations

1 site
  • Taipei Medical University - WanFang Hospital
    Taipei, Taiwan
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 1, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT01327560
Lead sponsor
Taipei Medical University WanFang Hospital
First posted
Apr 1, 2011
Start date
Feb 2011
Completion
Dec 2011 (estimated)
Last update
Apr 1, 2011

Study contacts

Tso-Hsiao Chen
principal investigator · Taipei Medical University WanFang Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion